Efficacy of Atorvastatin Loaded on Nano Particles on Cryptosporidium Parvum in Experimentally Infected Mice

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Nageeb M.M.; El Fakahany A.F.; Abd El Maaboud A.I.; Youssif S.H.; Hegab F.A.; Omar G.H.

Journal: Benha Medical Journal

Publisher: Benha University Faculty of Medicine

Publication Date: 5 July 2024

Volume / Issue: Volume 41 / Issue 6

Pages: 87–100

ISSN: 1110208X

DOI: 10.21608/bmfj.2024.267590.2014

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Bronze Open Access


Authors and Affiliations

Nageeb M.M., Medical Parasitology Department, Faculty of Medicine, Benha University, Egypt; El Fakahany A.F., Medical Parasitology Department, Faculty of Medicine, Benha University, Egypt; Abd El Maaboud A.I., Medical Parasitology Department, Faculty of Medicine, Benha University, Egypt; Youssif S.H., Medical Parasitology Department, Faculty of Medicine, Benha University, Egypt; Hegab F.A., Anatomical Pathology, Theodor Biharz Research Institute, Egypt; Omar G.H., Medical Parasitology Department, Faculty of Medicine, Benha University, Egypt


Abstract

Background: Cryptosporidium parvum is an intracellular coccidial protozoa that can lead to life-threatening impacts in immunocompromised hosts. Atorvastatin may be used to treat human cryptosporidiosis. Nanomedicine developments appear promising in treatment of cryptosporidiosis. Purpose: The aim of this work is to evaluate the efficacy of atorvastatin loaded on nano-particles on treatment of cryptosporidiosis. Methods: Cryptosporidium oocysts were obtained by collection of stools from naturally infected calves. Both Nitazoxanide (500 mg/kg/day) and Atorvastatin (40 mg/kg/day) either alone or loaded on silver nano particles (SNP)-were given to the selected immunosuppressed 110 mice. Assessment of drugs effect was done by parasitological, histopathological and serological assessment. Results: The highest group in reduction of number of oocysts recorded in combination group of Atorvastatin and Nitazoxanide loaded on SNP (95.1%). The highest level of serum GSH was recorded in negative control group (26±.5) and the least value recorded in positive control group (7.1±0.9). Combination of Nitazoxanide and Atorvastatin loaded on SNP achieved the highest increase in serum GSH level among treated groups (24.8±1.4). Examination of sections from different treated groups showed remarkable decrease in intestinal inflammation with decreased number of Cryptosporidium oocysts with best results in groups BVII (combination of Atorvastatin and Nitazoxanide) and BVIII (combination group of Atorvastatin and Nitazoxanide loaded on SNP)-showing significant statistical difference compared to positive control group BII. Conclusion: Atorvastatin (either alone or loaded on silver nanoparticles) in combination with Nitazoxanide seems to be more efficient and could be a good candidate in the treatment of cryptosporidiosis. © 2024, Benha University Faculty of Medicine. All rights reserved.


Keywords

Atorvastatin; Cryptosporidium parvum; Nitazoxanide; Silver nanoparticles


Citation Information

Scopus Citations: 3


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region